We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$63.1M
2
WW
WW International
WW
+$57.1M
3
HXL icon
Hexcel
HXL
+$57.1M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$54.4M
5
HQY icon
HealthEquity
HQY
+$47.7M

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANDV
151
DELISTED
Andeavor
ANDV
$30M 0.24%
229,000
-23,200
-9% -$3.05M
ZTS icon
152
Zoetis
ZTS
$32.5B
$30M 0.24%
352,230
-299,024
-46% -$25.2M
HZNP
153
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$29.9M 0.24%
+1,805,886
New +$27.5M
AOS icon
154
A.O. Smith
AOS
$8.82B
$29.7M 0.23%
502,793
+34,736
+7% +$2.19M
EPR icon
155
EPR Properties
EPR
$4.92B
$29.6M 0.23%
457,549
+177,525
+63% +$10.5M
EG icon
156
Everest Group
EG
$15.8B
$29.3M 0.23%
127,225
-18,775
-13% -$4.41M
PLAY icon
157
Dave & Buster's
PLAY
$361M
$29.3M 0.23%
615,426
– –
FOLD
158
DELISTED
Amicus Therapeutics
FOLD
$29M 0.23%
1,859,320
– –
CI icon
159
Cigna
CI
$79.6B
$27.9M 0.22%
164,285
+9,666
+6% +$1.67M
EVRI
160
DELISTED
Everi Holdings
EVRI
$27.6M 0.22%
3,839,352
– –
BCO icon
161
Brink's
BCO
$4.87B
$27.5M 0.22%
345,004
– –
INFN
162
DELISTED
Infinera Corporation Common Stock
INFN
$27.5M 0.22%
2,768,997
– –
BHVN
163
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$27.3M 0.21%
690,417
– –
CUZ icon
164
Cousins Properties
CUZ
$5.22B
$27.2M 0.21%
702,248
+44,744
+7% +$1.63M
BFAM icon
165
Bright Horizons
BFAM
$4.24B
$27M 0.21%
263,094
-390,584
-60% -$39.2M
GBCI icon
166
Glacier Bancorp
GBCI
$6.45B
$26.9M 0.21%
+696,212
New +$27.2M
TXT icon
167
Textron
TXT
$15.6B
$26.9M 0.21%
408,234
+59,750
+17% +$3.86M
WING icon
168
Wingstop
WING
$3.67B
$26.8M 0.21%
+514,786
New +$26.2M
MGM icon
169
MGM Resorts International
MGM
$11.8B
$26.6M 0.21%
915,154
-424,221
-32% -$13.7M
DRI icon
170
Darden Restaurants
DRI
$23.7B
$26.3M 0.21%
246,050
+190,050
+339% +$17.4M
SGEN
171
DELISTED
Seagen Inc. Common Stock
SGEN
$26.3M 0.21%
+395,659
New +$22.7M
OMCL icon
172
Omnicell
OMCL
$1.96B
$26.2M 0.21%
500,403
+338,403
+209% +$15.9M
FLR icon
173
Fluor
FLR
$6.89B
$26.2M 0.21%
+537,914
New +$28.2M
ALRM icon
174
Alarm.com
ALRM
$2.7B
$26.2M 0.21%
+648,459
New +$26.9M
SUPN icon
175
Supernus Pharmaceuticals
SUPN
$2.77B
$26.2M 0.21%
437,500
+268,025
+158% +$13.9M
5 6
7
8 9

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.